Skip to main content
. 2024 Nov 6;15:1479941. doi: 10.3389/fmicb.2024.1479941

Table 5.

Studies about the effects of H. pylori on IBD.

No. Study Year Journal Effect Mechanism
1 Immune response modulation in inflammatory bowel diseases by Helicobacter pylori infection (Balani et al., 2023) 2023 World Journal of Gastroenterology Protective effect H. pylori infection culminates in high levels of TGF-β and low levels of IL-17 and IL-22 on IBD. It also induces the differentiation of Tregs and the polarization of the M1 macrophage into M2 macrophage lineage. And the ability of H. pylori neutrophil-activating protein to reduce Th2 activity may be a possible explanation for the improvement of IBD
2 Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota (Bai et al., 2022) 2022 Chinese Medical Journal Protective effect H. pylori infection increased the diversity of the intestinal microbiota, reduced the abundance of Bacteroidetes, augmented the abundance of Firmicutes, and produced short-chain fatty acid-producing bacteria such as Akkermansia. All these factors may decrease vulnerability to IBD
3 New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease (Liang et al., 2022) 2022 Frontiers in Microbiology Protective effect The protective effect possibly due to the ability of H. pylori to inhibit the growth of other bacteria
4 Association Between Helicobacter pylori colonization and inflammatory bowel disease a systematic review and meta-analysis (Shirzad-Aski et al., 2021) 2021 Journal of Clinical Gastroenterology Protective effect H. pylori stimulated dendritic cells enter a semimature state, leading to the differentiation of immunosuppressive Tregs. Tregs can inhibit the transformation of naive Th0 cells to Th1 and Th17, which play a protective effect on IBD.
5 Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1α expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice 2020 International Immunopharmacology Protective effect Serum exosomes patients with H. pylori infection can promote NLRP12 expression in intestinal epithelial cells, and NLRP12 decreased chemokine MCP-1 and MIP-1α expression by inhibiting the Notch signaling pathway, which improved colitis symptoms in DSS-induced colitis mice
6 Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses (Piovani et al., 2019) 2019 Gastroenterology Protective effect H. pylori infection may reduce intestinal inflammation through Toll-like receptor 2 and interleukin 10 production, the inhibition of type I interferon and interleukin 12 production, and the accumulation of regulatory T cells
7 The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease (Zuo and Ng, 2018) 2018 Frontiers in Microbiology Protective effect H. pylori infection could induce immune tolerance and limit inflammatory responses
8 Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? (Hold et al., 2014) 2014 World Journal of Gastroenterology Protective effect The protective effect may conform to the “hygiene hypothesis” for the development of IBD